Company Information

As of 6/5/23
Country
U.S.
Headquarters
Canonsburg, Pa.
Industry
Pharmaceuticals
CEO
Scott A. Smith
Company Type
Public
Ticker
VTRS
Revenues ($M)
$16,263
Profits ($M)
$2,079
Market Value ($M)
$11,513
Employees
37,000
Market value as of March 31, 2023.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$16,262.7
-9.1%
Profits ($M)
$2,078.6
-
Assets ($M)
$50,022.2
-
Total Stockholder Equity ($M)
$21,072.3
-

Profit Ratios

Profit as % of Revenues
12.8%
Profits as % of Assets
4.2%
Profits as % of Stockholder Equity
9.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
1.71
EPS % Change (from 2021)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-

Total Return

Total Return to Investors (2022)
-13.8%
Total Return to Investors (5 year, annualized)
-
Total Return to Investors (10 year, annualized)
-

Viatris Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2022$17,88649.7%$-1,269$54,843$20,493
2021$11,946$-670$61,553$22,954
2020
FortuneAnalytics tout
Lists ranking Viatris
RANK256
Fortune 500 - 2023The Fortune 500, in its 69th year in 2023, ranks t...READ MORE